Treatment of choice for seasonal influenza is
**Core Concept**
Seasonal influenza is a highly contagious respiratory illness caused by the influenza virus, which affects millions of people worldwide each year. The treatment of choice for seasonal influenza involves antiviral agents that target the viral replication process, reducing the severity and duration of symptoms.
**Why the Correct Answer is Right**
The treatment of choice for seasonal influenza is the neuraminidase inhibitor oseltamivir (Tamiflu). Oseltamivir works by inhibiting the neuraminidase enzyme on the surface of the influenza virus, preventing the release of new viral particles from infected cells. This reduces the spread of the virus within the host and alleviates symptoms. Oseltamivir is effective against all three major types of influenza viruses (A, B, and C) and is recommended for treatment and prevention of seasonal influenza.
**Why Each Wrong Option is Incorrect**
**Option A:** Zanamivir (Relenza) is another neuraminidase inhibitor, but it is administered via inhalation and is not the first-line treatment for seasonal influenza.
**Option B:** Amantadine (Symmetrel) is an adamantane derivative that inhibits the M2 protein of influenza A virus, but it is no longer recommended for the treatment or prevention of seasonal influenza due to widespread resistance.
**Option C:** Ribavirin is a nucleoside analog that has antiviral activity against various viruses, including respiratory syncytial virus, but it is not the treatment of choice for seasonal influenza.
**Clinical Pearl / High-Yield Fact**
Neuraminidase inhibitors like oseltamivir are most effective when started within 48 hours of symptom onset, making prompt diagnosis and treatment crucial in managing seasonal influenza.
**Correct Answer: C. Ribavirin is a nucleoside analog that has antiviral activity against various viruses, including respiratory syncytiveirus, but it is not the treatment of choice for seasonal influenza.**